Nationwide Hepatitis C NAT+ Cardiac Transplant Experience
Status: Unknown
Location: See location...
Study Type: Observational
SUMMARY
In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Recipient of a proven HCV NAT+ donor heart.
• Re-transplant patients will be included.
Locations
United States
Texas
Baylor Scott & White Health Research Institute
RECRUITING
Dallas
Contact Information
Primary
Joost Felius, PhD
Joost.Felius@BSWHEALTH.ORG
214-818-8943
Time Frame
Start Date: 2019-09-16
Completion Date: 2023-12
Participants
Target number of participants: 500
Authors
Related Therapeutic Areas
Sponsors
Leads: Baylor Research Institute